Journal: Nucleic Acids Research
Article Title: Phosphorylation-dependent modulation of the Lamin A/C–EZH2 complex regulates epithelial–mesenchymal plasticity
doi: 10.1093/nar/gkaf1464
Figure Lengend Snippet: Phosphorylation-dependent regulation of EZH2 and Lamin A/C during EMT and MET. Representative mid-optical sections of immunofluorescence images showing the effect of Lamin A and EZH2 mutants on EMT (in MCF10A) and MET (in MDAMB231). MCF10A (A, C) and MDAMB231 (B, D) . Cells were transduced with full-length, phospho-deficient, or phospho-mimetic constructs of Lamin A (A, B) or EZH2 (C, D) following doxycycline-induced knockdown (0.5 μg/ml, 48 h) of endogenous Lamin A/C or EZH2. EMT was induced in MCF10A cells by TGF-β treatment (10 ng/ml, ∼7 days), while MET was induced in MDAMB231 cells by stable, constitutive overexpression of GRHL2. EZH2 was immunostained in green; E-cadherin and Vimentin were immunostained in red. Lamin A constructs were GFP-tagged. Nucleus (blue, DAPI). Scale bar ∼10 μm. (E, F) Immunoblot analysis of EMT marker expression in MCF7 and MCF10A cells upon Lamin A/C knockdown and rescue with full-length, phospho-deficient (S22A), or phospho-mimetic (S22D) Lamin A-GFP. EMT was induced by TWIST1 overexpression (∼48 h) in MCF7 cells or by 10ng/ml TGF-β (∼7 days) in MCF10A cells. (G) EM marker expression in cells with Lamin A/C knockdown was rescued with full-length, phospho-deficient (S22A) or phospho-mimetic (S22D) Lamin A/C. MET was induced by GRHL2 overexpression. (H, I) Immunoblot analysis of EMT marker expression in MCF7 and MCF10A cells upon EZH2 knockdown and rescue with full-length, phospho-deficient (T345A), or phospho-mimetic (T345D) EZH2-FLAG. EMT was induced by TGF-β (∼7 days) in MCF10A cells or by TWIST1 overexpression (∼48 h) in MCF7 cells. (J) EM marker expression in cells with EZH2 knockdown rescued with full-length, phospho-deficient (T345A), or phospho-mimetic (T345D) EZH2. MET was induced by GRHL2 overexpression.
Article Snippet: Immortalized human breast epithelial cell line MCF10A (CRL-10317) and cancer cell lines MCF7 (HTB-22), and MDAMB231 (HTB-26) were obtained from ATCC.
Techniques: Phospho-proteomics, Immunofluorescence, Transduction, Construct, Knockdown, Over Expression, Western Blot, Marker, Expressing